FDA approves OTC availability of Sanofi's Nasacort

Sanofi announced Friday that the FDA has granted its allergy spray Nasacort approval to be sold over the counter. The medication, which previously was sold via prescription, is the first steroid nasal spray to be granted approval for OTC use.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Briefs: